Shares of Pfizer Inc
fell 1.3 percent to $15.50 in premarket trading on Wednesday, after the Dow component reported its second-quarter results and gave a full-year outlook.

(Reporting by Ryan Vlastelica; Editing by Theodore d'Afflisio)